Gubra is looking for an AI Enablement & Governance Architect to build and drive our enterprise approach to AI adoption, governance and value realization across Biotech, CRO, Group Functions and DDIT. This is a technology role within DDIT, requiring strong technical understanding of modern AI architectures, platforms, data, software integration and enterprise adoption.
AI will be treated as a horizontal enterprise capability, with enablement and value creation as the primary objectives and governance as the guardrail. This role will act as DDIT’s central owner for AI governance and responsible AI, while also driving opportunity shaping, prioritization, adoption and scale. Product and Engineering teams remain accountable for solution delivery.
We believe the value of AI will come not from individual tools or models alone, but from how we combine AI with Gubra’s scientific expertise, data, processes and digital capabilities to improve how we discover, develop and operate.
Your Responsibilities
What You Bring
You combine a strong understanding of AI and ML with technical product thinking, practical business judgement and the ability to operate across science, business, governance and technology.
You are likely to come from an AI, digital product, technology, architecture or data background, with the technical credibility to work closely with engineering teams while operating effectively with business leaders.
You are comfortable working in an environment where AI capabilities are evolving rapidly, and where organisations need to learn quickly while maintaining appropriate control.
You start with the business or scientific problem and the value to be created, not with the technology.
Required Experience
Preferred Experience
Contact and application
Please apply no later than October 18, 2026, by uploading your motivated cover letter and resume on our website.
If you have questions regarding practical matters, you are welcome to contact HR. Questions regarding role-specific details will be addressed during the interview.
We are looking forward to receiving your application.
About Gubra
Gubra is a disease-agnostic techbio company specialized in peptide-based drug discovery and development as well as preclinical contract research services striving for excellence at all levels. We insist on doing things efficiently – and often differently - to reach the results we aim for. Our vision is to become leaders in the path towards a more sustainable and healthier world. We do that by facilitating the discovery of new medicine, and by acting and inspiring others to fight the ongoing climate and biodiversity crises.
Gubra’s activities are focused on the early stages of drug development and are organised in two main highly synergistic business areas: Biotech and CRO Services. We generate our revenue by performing research for life science companies as well as by partnering projects from our discovery and development pipeline.
Our therapeutic focus is within metabolic and fibrotic diseases, and we specialize in in vivo pharmacology, ex vivo assays, drug profiling, histology, stereology and whole brain and organ imaging. In addition, we offer a full palette of advanced transcriptomics. Our ML/AI-driven peptide drug discovery platform streaMLine enables us to rapidly develop a peptide hit into a non-clinical candidate ready for development. Through a constant focus on high quality, scientific excellence, speed, and solid teamwork we have established ourselves as a highly professional and competent partner in the market.
People are our greatest asset, and our team consists of around 300 employees of which many are located in Hørsholm, Denmark. The mix of people from different cultures and educational backgrounds combined with our entrepreneurial mindset have greatly impacted our working environment, which is characterized by entrepreneurial drive, scientific curiosity, and teamwork – we join forces!